Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rothe

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Physics in Medicine and Biology|March 16, 2016
Light scattering microscopy measurements of single nuclei compared with GPU-accelerated FDTD simulationsJulian Stark, Thomas Rothe, Steffen Kieß, et al.
Praxis|June 12, 2024
[New manifestation of a type 2-inflammation in the upper respiratory tract with nasal polyposis under treatment with an asthma biologic]Anita E Gander, Mona Leuenberger, Yves Brand, et al.
Journal of Asthma and Allergy|May 23, 2014
Differential serum protein markers and the clinical severity of asthmaNorbert Meyer, Sarah Janine Nuss, Thomas Rothe, et al.
The European Journal of Neuroscience|January 28, 2005
GluR- and TrkB-mediated maturation of GABA receptor function during the period of eye openingChristian Henneberger, René Jüttner, Sonja A Schmidt, et al.
Respiration; International Review of Thoracic Diseases|May 7, 2018
Associations between Dietary Patterns and Post-Bronchodilation Lung Function in the SAPALDIA CohortNina Steinemann, Leticia Grize, Marco Pons, et al.
European Journal of Pediatrics|February 8, 2018
Is there a gender-specific association between asthma and carotid intima media thickness in Swiss adolescents?Julia Dratva, Seraina Caviezel, Emmanuel Schaffner, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Journal of Asthma and Allergy|December 30, 2024
Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational StudyDaiana Stolz, Claudio Schuoler, Florian Charbonnier, et al.
Journal of Asthma and Allergy|May 1, 2026
Clinical Remission in Patients with Severe Eosinophilic Asthma - A Single-Arm Observational Study with BenralizumabNikolay Pavlov, Pierre-Olivier Bridevaux, Peter Jandus, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Physics in Medicine and Biology|March 16, 2016
Light scattering microscopy measurements of single nuclei compared with GPU-accelerated FDTD simulationsJulian Stark, Thomas Rothe, Steffen Kieß, et al.
Praxis|June 12, 2024
[New manifestation of a type 2-inflammation in the upper respiratory tract with nasal polyposis under treatment with an asthma biologic]Anita E Gander, Mona Leuenberger, Yves Brand, et al.
Journal of Asthma and Allergy|May 23, 2014
Differential serum protein markers and the clinical severity of asthmaNorbert Meyer, Sarah Janine Nuss, Thomas Rothe, et al.
The European Journal of Neuroscience|January 28, 2005
GluR- and TrkB-mediated maturation of GABA receptor function during the period of eye openingChristian Henneberger, René Jüttner, Sonja A Schmidt, et al.
Respiration; International Review of Thoracic Diseases|May 7, 2018
Associations between Dietary Patterns and Post-Bronchodilation Lung Function in the SAPALDIA CohortNina Steinemann, Leticia Grize, Marco Pons, et al.
European Journal of Pediatrics|February 8, 2018
Is there a gender-specific association between asthma and carotid intima media thickness in Swiss adolescents?Julia Dratva, Seraina Caviezel, Emmanuel Schaffner, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Journal of Asthma and Allergy|December 30, 2024
Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational StudyDaiana Stolz, Claudio Schuoler, Florian Charbonnier, et al.
Journal of Asthma and Allergy|May 1, 2026
Clinical Remission in Patients with Severe Eosinophilic Asthma - A Single-Arm Observational Study with BenralizumabNikolay Pavlov, Pierre-Olivier Bridevaux, Peter Jandus, et al.
Pageof 8